5Schmidt-Wolf IG, Negrin RS, Kiem HP, et ol. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J]. J Exp Med, 1991, 174(1): 139-491.
6Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3^+CD56^+ killer cells[J]. Ann Hematol, 1997, 74(2):51-56.
7Shi M, Fu J, Shi F, et al. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection[J]. Clin Immunol, 2009, 132(1):43-54.
8Ma YJ, He M, Han JA, et al. A Clinical study of HBsAg - activated dendritic cells and cytokine - induced killer dells during the treatment for chronic hepatitis B [ J ] . Scandinavian journal of immunology, 2013, 78 (4) : 387 -393.
9Schmidt:Wolf GD, Negrin RS, Schmidt-Wolf Igh. Activated T cells and cytokine-indueed CD3 + CD56 + killer cells [ J] . Annals of hematolo- gy, 1997, 74 (2): 51-56.
10Dudley M E,Wunderlich J R,Robbins P F. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes[J].Science,2002,(5594):850-854.
